Picodya
Picodya develops cartridge-based diagnostic systems built around its PicoFluidics technology. Its B-Matrix platform combines small-volume fluid handling, image processing and automation to run molecular assays and immunoassays for clinical and research workflows.
2026-09-14
Qureator
Qureator develops Curiochips, a three-dimensional organ-on-chip platform for modeling human biology. The company combines engineered tissue systems with data analysis to study disease and treatment responses during preclinical drug development.
2026-09-14
1DROP
1DROP combines capillary-driven microfluidic chips with optical detection for portable diagnostics. Its chips integrate sample handling, reagents and reaction chambers to measure multiple biomarkers from small samples without separate fluid-control equipment.
2026-09-14
Baebies
Baebies develops diagnostic platforms based on digital microfluidics. Its systems move tiny droplets with electrically controlled surfaces to run different assay types, including molecular, chemistry, coagulation and immunoassay tests, within compact instruments.
2026-09-14
LIOM
LIOM is developing wearable sensing technology for non-invasive biochemical monitoring, beginning with glucose. Formerly called Spiden, the company is working toward continuous measurements through the skin; its platform remains a development effort rather than an established consumer diagnostic.
2026-09-14
DLOC Biosystems
DLOC Biosystems develops organ-on-chip devices and automated systems for connecting multiple tissue models. Its platforms combine three-dimensional scaffolds, controlled fluid handling and tissue measurements to support preclinical studies of drug effects and organ interactions.
2026-09-14
Syntopia
Syntopia combines microfluidic systems, perfused human tissue cultures and computational models to study drug responses. Its platform generates spatial and temporal measurements from three-dimensional models, with a focus on evaluating antibody-drug conjugates before clinical testing.
2026-09-14
Level Zero Health
Level Zero Health is developing wearable biosensors for continuous hormone monitoring. Its approach uses DNA-based sensing to measure biochemical changes in interstitial fluid, with an intended focus on reproductive health and other hormone-related applications.
2026-09-14
TissUse
TissUse develops HUMIMIC multi-organ-chip systems that connect human tissue models under controlled conditions. Its platforms and research services support investigations of compound metabolism, toxicity and interactions between organs during preclinical testing.
2026-09-14
NanoCellect
NanoCellect develops microfluidic flow-cytometry instruments for analyzing and sorting cells. Its WOLF platform uses disposable microfluidic cartridges to support single-cell research, cell-line development and other experiments that need selected populations of viable cells.
2026-09-14
Nicoya
Nicoya develops biosensing instruments for studying how molecules bind and interact. Its Alto platform combines digital microfluidics with surface plasmon resonance, allowing researchers to characterize molecular interactions using small samples in automated assay workflows.
2026-09-14
Kytopen
Kytopen develops Flowfect, a cell-engineering platform that combines microfluidic flow with electric fields to deliver genetic payloads into cells. The MIT spinout designs its tools to connect early research with larger-scale cell-therapy manufacturing.
2026-09-14